Silver Creek Pharmaceuticals
Adam Whitman is a Research Associate with experience in the biopharmaceutical industry, currently employed at Silver Creek Pharmaceuticals since May 2022. Prior to this role, Adam worked at Ascella BioSystems and Inova Diagnostics, where contributions included the design of novel diagnostic assays for autoimmune diseases. Adam began a career in research as an Undergraduate Research Assistant at The Scripps Research Institute. Adam holds a Bachelor of Science degree in Human Biology from UC San Diego, earned in 2017.
This person is not in any teams
Silver Creek Pharmaceuticals
Silver Creek Pharmaceuticals, a biotechnology company, develops protein therapeutics to treat cardiovascular diseases. The company's mission is to provide smart growth factors to those suffering from organ damage as a result of an acute injury. Scp776 is currently being tested in clinical trials for the treatment of stroke.